These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 19552519

  • 1. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K, Kopelikova I.
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K.
    Toxicology; 2008 Jan 20; 243(3):311-6. PubMed ID: 18054821
    [Abstract] [Full Text] [Related]

  • 3. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J, Karasova JZ, Caisberger F, Musilek K, Kuca K, Jung YS.
    J Enzyme Inhib Med Chem; 2010 Aug 20; 25(4):480-4. PubMed ID: 20233085
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Misik J, Caisberger F, Bajgar J.
    J Appl Toxicol; 2010 Mar 20; 30(2):120-4. PubMed ID: 19746406
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J, Kuca K, Cabal J, Paar M.
    J Toxicol Environ Health A; 2006 Oct 20; 69(20):1875-82. PubMed ID: 16952906
    [Abstract] [Full Text] [Related]

  • 8. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K, Bajgar J.
    Clin Toxicol (Phila); 2009 Jan 20; 47(1):72-6. PubMed ID: 18686075
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K.
    J Enzyme Inhib Med Chem; 2008 Dec 20; 23(6):776-80. PubMed ID: 18608751
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice.
    Kassa J, Karasova JZ, Kuca K, Musilek K.
    Drug Chem Toxicol; 2010 Jul 20; 33(3):227-32. PubMed ID: 20429807
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
    Kassa J, Karasova JZ, Caisberger F, Bajgar J.
    Toxicol Mech Methods; 2009 Nov 20; 19(9):547-51. PubMed ID: 19839724
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J, Karasova JZ, Musilek K, Kuca K.
    Toxicol Mech Methods; 2009 Jun 20; 19(5):346-50. PubMed ID: 19778210
    [Abstract] [Full Text] [Related]

  • 17. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J, Jun D, Kuca K.
    J Enzyme Inhib Med Chem; 2007 Jun 20; 22(3):297-300. PubMed ID: 17674811
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.